Trademark: 90387051
Word
TYKRUVA
Status
Pending
Status Code
731
Status Date
Tuesday, January 2, 2024
Serial Number
90387051
Mark Type
4000
Filing Date
Wednesday, December 16, 2020
Published for Opposition
Tuesday, November 22, 2022

Trademark Owner History
Bristol-Myers Squibb Company - Owner At Publication

Classifications
5 Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use for immunotherapy, including T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use
The wording "TYKRUVA" has no meaning in a foreign language.

Trademark Events
Jan 4, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 2, 2024
Sou Extension 2 Granted
Jan 2, 2024
Sou Extension 2 Filed
Jan 2, 2024
Sou Teas Extension Received
Aug 2, 2023
Teas Change Of Correspondence Received
Aug 2, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Aug 2, 2023
Teas Change Of Owner Address Received
Jul 12, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 10, 2023
Sou Extension 1 Granted
Jul 10, 2023
Sou Extension 1 Filed
Jul 10, 2023
Sou Teas Extension Received
Jan 17, 2023
Noa E-Mailed - Sou Required From Applicant
Nov 22, 2022
Official Gazette Publication Confirmation E-Mailed
Nov 22, 2022
Published For Opposition
Nov 2, 2022
Notification Of Notice Of Publication E-Mailed
Oct 14, 2022
Approved For Pub - Principal Register
Jul 19, 2022
Examiner's Amendment Entered
Jul 19, 2022
Notification Of Examiners Amendment E-Mailed
Jul 19, 2022
Examiners Amendment E-Mailed
Jul 19, 2022
Examiners Amendment -Written
Jan 26, 2022
Notification Of Final Refusal Emailed
Jan 26, 2022
Final Refusal E-Mailed
Jan 26, 2022
Final Refusal Written
Nov 17, 2021
Teas/Email Correspondence Entered
Nov 17, 2021
Correspondence Received In Law Office
Nov 17, 2021
Teas Response To Office Action Received
May 19, 2021
Notification Of Non-Final Action E-Mailed
May 19, 2021
Non-Final Action E-Mailed
May 19, 2021
Non-Final Action Written
May 11, 2021
Assigned To Examiner
Feb 25, 2021
New Application Office Supplied Data Entered
Dec 19, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24